Adicet Bio

Adicet Bio

Adicet Bio

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

2014ActiveBoston, United States
Rate

About

Adicet Bio is a clinical-stage biotechnology company focused on discovering and developing off-the-shelf allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. Their proprietary platform engineers these cells with chimeric antigen receptors (CARs) to provide durable activity in patients. The company's lead product candidate, prulacabtagene leucel (prula-cel), is being developed for autoimmune indications and has received Fast Track Designation from the FDA for certain conditions.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Adicet Bio?

People comparing tools land here. Get listed beside these.

Copy Adicet Bio's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
adicetbio.com
Headquarters
Boston, United States
Founded
2014
Founder
Aya Jakobovits
Total funding
$389M (Registered Direct Offering)
Business model
B2B

Funding rounds

Funding rounds raised by Adicet Bio
DateRoundAmountLead investors
7 Oct 2025Registered Direct Offering$80M
25 Jan 2024Follow-on Offering$98M
2 Oct 2020Series B$80M
2 Oct 2019Series B$80M
27 Jan 2016Series A$51MOrbiMed

Tech stack

Detected on adicetbio.com, last scanned 18 Nov 2026.

Frontend
jQuery
Analytics
Google Analytics 4
Hosting
AWS
Email provider
Mimecast
Cookie consent
OneTrust

Benchmarking

See how your site ranks against 16,849 startups

Adicet Bio sits in the 51st percentile for Domain Rating. Check where yours lands, free.

Adicet Bio has a Domain Rating of 42, the 51st percentile of 16,849 startups we track.

Scores

Measured, not editorial

42

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours
23

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Bottom 25%

Scan yours
60

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Below median

PageSpeed
89

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Top 25%

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Adicet Bio scores 23. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Adicet Bio changes

Used Adicet Bio? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Who owns Adicet Bio?

Adicet Bio is privately held, owned by its founders and investors. OrbiMed has backed 2 of the 5 rounds on record since January 2016, ahead of Novartis Venture Fund (2) and Pontifax (2), so it is likely among the largest outside shareholders. Exact stakes are not public.

Are there companies like Adicet Bio?

Yes. We list 6 companies like Adicet Bio, including TippingPoint Biosciences, BeiGene and Cue Biopharma. Adicet Bio has raised more than 4 of the 6 with funding on record.

Is Adicet Bio trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Adicet Bio is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Adicet Bio raised?

Adicet Bio has raised a total of $389M in funding. The most recent round on record is Registered Direct Offering.

SEC filings, insider activity, nonprofit links and pay benchmarks for Adicet Bio:

Company details: from public sources. Funding: 5 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Adicet Bio and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini